NCT07533942Phase 2Recruiting

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Study sponsor: Jazz Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-10-25Estimated
Enrollment · participants30Estimated
Source updated2026-10-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source